NIMH Names New Director

Joshua Gordon of Columbia University Medical Center will lead the National Institute of Mental Health.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NIHThe National Institute of Mental Health (NIMH) has named psychiatrist Joshua Gordon of Columbia University Medical Center in New York City its next director. Gordon, who succeeds past NIMH Director Thomas Insel, who left the agency to join Google Life Sciences last September. Gordon is expected to take the reins from interim NIMH Director Bruce Cuthbert next month, according to a National Institutes of Health (NIH) announcement.

“Josh is a visionary psychiatrist and neuroscientist with deep experience in mental health research and practice,” NIH Director Francis Collins said in the statement. “He is exceptionally well qualified to lead the NIMH research agenda to improve mental health and treatments for mental illnesses.”

In addition to seeing patients at Columbia, Gordon also studies mouse models with psychiatric disease–associated mutations. “Josh is certainly coming from a basic science side,” Carrie Bearden, a neuroscientist at the University of California, Los Angeles, told Science. “He really cares about taking the findings in the animal models and looking how it’s really convergent with patient findings.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery